JOHN WASHINGTON: Open Payments
NPI 1376885996 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,044 in 88 payments from 15 companies in 2025. Trend: 2023 $1,424 · 2024 $2,005 · 2025 $2,044
Food & beverage: $2,044
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $566 |
| ABBVIE INC. | 20 | $504 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $293 |
| Phathom Pharmaceuticals, Inc. | 7 | $96 |
| PFIZER INC. | 5 | $78 |
| GENZYME CORPORATION | 3 | $77 |
| Regeneron Healthcare Solutions, Inc. | 3 | $75 |
| Gilead Sciences, Inc. | 4 | $70 |
| Intercept Pharmaceuticals, Inc. | 3 | $63 |
| Ardelyx, Inc. | 3 | $60 |
Products named: TREMFYA, CREON, ENTYVIO, DUPIXENT, SKYRIZI, RINVOQ, VOQUEZNA, GATTEX.
Industry payments across NC — which companies pay providers there.
